Salesforce Is Still Undervalued Despite a 28% Gain Over the Past Month

Salesforce shares are up 28% over the past month as SaaSpocalypse fears fade and agentic AI initiatives lift momentum. The article cites fiscal 2027 Q1 (ended April 30) revenue up 13% YoY, with current remaining performance obligations of $33.6B (+14% YoY), and AgentForce crossing $1B in annual recurring revenue; combined Data 360 and AgentForce reached $3.4B ARR (+200%+ YoY). Salesforce trades at a P/E of 24, down from above 40 less than a year ago, and management guided for 10%-11% YoY revenue growth in fiscal 2027 Q2, with net income up 37% YoY.

Analysis

The key market mechanism is not “AI saves software,” but that CRM is trying to convert workflow control into a monetization layer on top of existing spend. If agentic features raise attach rates and unlock usage-based expansion, the stock deserves a higher quality multiple than a pure seat-growth SaaS name because revenue becomes less linear and more embedded in customer operations. That also creates second-order winners in the infrastructure stack: higher inference activity should spill through to hyperscaler and GPU demand even if CRM captures only a small slice of value.

The near-term catalyst is the next earnings cycle, where the market will care less about narrative and more about whether AI activity shows up in cRPO, billings, and margin leverage. The falsifier is simple: if usage metrics rise but deferred revenue growth and net-new business do not accelerate, the AI story becomes a retention defense rather than a growth engine. Over 3-6 months, the setup stays constructive as long as guidance holds above low-double-digit growth; over 6-18 months, the bigger risk is bundling pressure that improves adoption but caps incremental ARPU.

Contrarianly, the rally may still be underdone if investors are only pricing CRM as a mature subscription compounder; the more valuable version is an enterprise orchestration layer with proprietary data and switching costs. But the consensus may also be overextrapolating token growth into durable monetization, which often leads to front-loaded enthusiasm and then slower monetization than the market models. That argues for buying pullbacks, not chasing strength after a 1-month rerating run.

Key Decisions for Investors

• Long CRM on any post-earnings pullback or if it retests the breakout zone; 1-3 month upside is another 10-15% if management confirms AI-driven attach and does not soften FY27 guidance. Invalidate on revenue guidance below ~10% growth or meaningful cRPO deceleration.
• Pair trade: long CRM / short a basket of higher-multiple, less-proven enterprise SaaS names (e.g., WDAY, HUBS) over the next 1-3 months. Thesis is that platform incumbents can monetize AI through workflow lock-in while point solutions face bundling pressure; cover the short if CRM narrative broadens into sector-wide re-rating.
• Watch-list the AI infrastructure beneficiaries (NVDA, hyperscaler proxies) for a secondary trade if CRM commentary implies sustained token growth. If enterprise AI spend is real, compute suppliers should see the cleanest second-order demand lift over the next 2-4 quarters.